Journal
LEUKEMIA & LYMPHOMA
Volume 51, Issue 6, Pages 1108-1114Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/10428191003786766
Keywords
Acute promyelocytic leukemia (APL); all-trans retinoic acid (ATRA); retinoids
Categories
Funding
- NIH [1R01HL082946-01, CA121192]
- Gabrielle Angel Foundation
- Hershaft Family Foundation
- American Cancer Society
- Immunooncology Training Program [T32 CA009173]
- MDS foundation
- Department of Veterans Affairs
- NATIONAL CANCER INSTITUTE [P30CA060553, T32CA009173, R01CA121192] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082946] Funding Source: NIH RePORTER
Ask authors/readers for more resources
The binding of all-trans retinoic acid (ATRA) to retinoid receptor-alpha (RAR-alpha) relieves transcriptional repression induced by the promyelocytic leukemia-retinoic acid receptor (PML-RAR) oncoprotein. The ATRA molecule contains a cyclohexenyl ring, a polyene chain containing conjugated double alkene bonds, and a terminal carboxyl group. To determine the contributions of these structural components of ATRA to its clinical efficacy, we synthesized three novel retinoids. These consisted of either a modified conjugated alkene backbone with an intact acid moiety (13a) or a modified conjugated alkene backbone and conversion of the acid group to either an ester (13b) or an aromatic amide (13c). Reporter assays demonstrated that compound 13a successfully relieved transcriptional repression by RAR-alpha, while 13b and 13c could not, demonstrating the critical role of the acid moiety in this binding. However, only ATRA was able to significantly inhibit the proliferation of APL cells while 13a, 13b, or 13c was not. Furthermore, only 13a led to partial non-significant differentiation of NB4 cells, demonstrating the importance of C9-C10 double bonds in differentiation induced CD11 expression. Our results demonstrate that both the acid moiety and conjugated double bonds present in the ATRA molecule are important for its biological activity in APL and have important implications for the design of future novel retinoids.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available